ESCMID

@ESCMID · Basel · joined 22 Jan 2010

The European Society of Clinical Microbiology and Infectious Diseases Improving the diagnosis, treatment and prevention of infection-related diseases

38 299Followers

3 849Following

17 986Posts total

10.1KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views1 492this account1 005median for 10K–100K

Reach, %3.90%this account3.31%median for 10K–100K

Engagement, %0.53%this account2.01%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	1 492	1 005	1.48×
Reach (views ÷ followers)	3.90%	3.31%	1.18×
Engagement rate	0.53%	2.01%	0.27×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.4K23 Jan

1.5K2 Sep

1.7K3 Sep

1.1K4 Sep

1.5K5 Sep

9366 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.35%23 Jan

0.87%2 Sep

0.00%3 Sep

0.37%4 Sep

1.25%5 Sep

0.53%6 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 2.01%.

What the audience does

Likes53.0%35 in total

Reposts22.7%15 in total

Quotes4.5%3 in total

Bookmarks19.7%13 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

6 Sep

Daily snapshots since 06 Sep 2026; the dashed line is the starting count.

Latest posts

⏳ Registration deadline extended! https://t.co/RLpfdzrZG9 Build practical clinical research skills at this onsite course, covering study design, bias reduction, scientific writing and the latest in clinical trial methodology. Registration closes on Tues, 15 Sep! https://t.co/ML 936 views · 3 likes · 1 reposts · 0 replies 06 Sep 2026 · Open on X →

🤝 Sepsis management meets antimicrobial stewardship in the ICU. ESICM & ESCMID come together for a webinar on balancing timely sepsis treatment with responsible antimicrobial use. 🗓️ 08 Sept | 16:00–17:00 CEST Join the livestream: https://t.co/BfafhyRP5c https://t.co/9Kt4G 1.5K views · 13 likes · 5 reposts · 0 replies 05 Sep 2026 · Open on X →

This online course addresses emerging antimicrobial resistance, virulence, and the critical role of anaerobes in infectious diseases, equipping participants with the knowledge to effectively work with this important group of organisms. Register today: https://t.co/wEuhhSU8hO htt 1.1K views · 2 likes · 2 reposts · 0 replies 04 Sep 2026 · Open on X →

https://t.co/20Rx12S3jz Watch Philip Packer highlight the focused nature of GAMRIC with a solution-oriented approach allowing funders to look for new opportunities and set their priorities based on the challenges we face today. Register for #GAMRIC2026: https://t.co/4Wc3DZmtIC 1.7K views · 0 likes · 0 reposts · 0 replies 03 Sep 2026 · Open on X →

🦴🦠 This online course focuses on implant-associated infections, with special emphasis on prosthetic joint and fracture-related infections from infectious diseases, microbiology, and orthopaedic perspectives. 💡 Learn more and sign up today: https://t.co/McNnoHo9VD https://t.co/XC 1.5K views · 10 likes · 3 reposts · 0 replies 02 Sep 2026 · Open on X →

Enhance your skills in publishing your research manuscripts with this upcoming ESCMID Course organised by our journals @CMIJournal and CMI Communications! Attendants receive insights from journal editors and authors and participate in hands-on sessions. https://t.co/MZTfMTduH8 h 3.4K views · 7 likes · 4 reposts · 0 replies 23 Jan 2025 · Open on X →